Join the Ozempic group to help and get support from people like you.
Ozempic News (Page 6)
Wegovy, Ozempic Help Folks Lose Weight, But How?
TUESDAY, Oct. 10, 2023 – As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution. The drugs are not...
GI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss
FRIDAY, Oct. 6, 2023 – Use of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss is associated with increased risks for pancreatitis, gastroparesis, and bowel obstruction compared...
Tirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 – Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European...
Durable Reductions in HbA1c, Body Weight Seen With Semaglutide
WEDNESDAY, Oct. 4, 2023 – Use of once-weekly subcutaneous semaglutide is associated with sustained reductions in hemoglobin A1c (HbA1c) and body weight, according to a study presented at the annual...
Racial, Ethnic Differences Seen for Benefits of Antihyperglycemic Agents
THURSDAY, Sept. 28, 2023 – There are racial/ethnic differences in the cardiorenal effects of sodium-glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists...
Risk of Ileus Added to Ozempic Label
WEDNESDAY, Sept. 27, 2023 – Ozempic will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made by Novo...
FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
WEDNESDAY, Sept. 27, 2023 – Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food...
Diabetes Drug Maker, Sues Over Compounded Versions of Mounjaro
WEDNESDAY, Sept. 20, 2023 – Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are t...
In Small Study, Ozempic Helped People With Type 1 Diabetes Quit Insulin Treatments
THURSDAY, Sept. 7, 2023 – The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow...
Should Kids Take Ozempic, Wegovy? The Idea Has Some Experts Worried
WEDNESDAY, Aug. 30, 2023 – Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn’t mean they’re good for everyone. Glucagon-like peptide-1 receptor agonists (GLP-1RA) ma...
ESC: Semaglutide Beneficial for HFpEF Patients With Obesity
TUESDAY, Aug. 29, 2023 – For patients with heart failure with preserved ejection fraction and obesity, semaglutide is associated with a larger reduction in symptoms and physical limitations,...
Semaglutide Can Cut Prevalence of Obesity, CVD in Eligible U.S. Adults
TUESDAY, Aug. 22, 2023 – Semaglutide treatment among eligible U.S. adults can reduce the prevalence of obesity and cardiovascular disease (CVD) events, according to a study published online Aug. 14...
Wegovy Lowered Users' Heart Risks in New Trial
TUESDAY, Aug. 8, 2023 – A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious...
Glycemic Control Superior With Semaglutide 25 and 50 mg in Type 2 Diabetes
FRIDAY, Aug. 4, 2023 – Once-daily semaglutide 25 mg or 50 mg is superior to 14 mg for glycemic control among adults with type 2 diabetes, according to a study published online June 25 in The Lancet....
Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused 'Stomach Paralysis'
THURSDAY, Aug. 3, 2023 – A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Cardiovascular Risk Reduction, Diabetes, Type 2